Because the results showed a significant increase of PDE10A in the pulmonary hypertensive vasculature, we addressed the specific contribution of PDE10A to the vascular remodeling in PAH by employing small interfering RNA (siRNA) or an inhibitor in our in vitro and in vivo studies. This evidence concerns the gene PDE10A and pulmonary arterial hypertension.